Last reviewed · How we verify
NCT03466255: VIBE
Early Detection of Cardiovascular Disease
trial testing Ultrasound in Atheroma in 610 participants. Completed in 11 January 2022.
8 June 2021
Quick facts
| Lead sponsor | Dr. Amer Johri |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 610 |
| Start date | 6 December 2016 |
| Primary completion | 8 June 2021 |
| Estimated completion | 11 January 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Ultrasound
Conditions studied
- Atheroma — all drugs for Atheroma →
- Cardiac Disease — all drugs for Cardiac Disease →
- Vascular Diseases — all drugs for Vascular Diseases →
- Atherosclerosis — all drugs for Atherosclerosis →
Sponsor
Dr. Amer Johri
Who can join
18 and older, any sex, with Atheroma or Cardiac Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators plan to evaluate the correlation between carotid plaque enhancement on Contrast-enhanced ultrasound (CEUS), significant coronary artery disease (CAD), and cardiovascular (CV) outcomes in a systematic manner. The investigators hypothesize that increased levels of CEUS-detected vulnerable carotid plaque will be predictive of CV risk determined by angiography and future cardiovascular events.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03466255
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasound
Trials testing the same drug.
- NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
- NCT07505433 — Ultrasound Monitoring of Bone Healing in Ilizarov Bone Transport · not yet recruiting
- NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
- NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
- NCT07169890 — Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris · NA · completed
Other recruiting trials for Atheroma
Currently open trials in the same condition.
- NCT07252830 — Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid an · recruiting
Other Dr. Amer Johri trials
Trials by the same sponsor.
- NCT05416385 — Carotid Intraplaque Neovascularization Combined With Stress Echo · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03466255 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. Amer Johri
- Last refreshed: 9 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03466255.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing